Projects per year
Prof Martin Hoyle is a Professor of Health Innovation and Evaluation at the Macquarie University Centre for the Health Economy (MUCHE).
He now leads a team of researchers in MUCHE that work on submissions for the Australian Medical Services Advisory Committee (MSAC) and critique pharmaceutical company submissions to the Australian Pharmaceutical Benefits Advisory Committee (PBAC).
Prof Hoyle has evaluated drugs in many clinical areas including various cancers (chronic lymphocytic leukaemia, chronic myeloid leukaemia, multiple myeloma, neuroendocrine tumours, colorectal cancer, gastro-intestinal stromal tumours, renal cell carcinoma, soft tissue sarcoma), chemotherapy-induced anaemia, multiple sclerosis, Alzheimer's disease. Other evaluations include vaccines for influenza, cochlear implants for hearing, diagnostic tests for Lynch Syndrome, tests for pre-term labour in women, influenza vaccines. He has defended Assessment Group reports at 34 UK NICE Appraisal Committee meetings and 2 ESC meetings in Australia.
He has published papers on HTA methodology, specifically on assumptions regarding appropriate patient cohorts to model, assumptions for future drug prices and a method to recreate and analyse individual patient data using only summary survival data.
He was the external examiner for the MSc in Health Economics and Decision Modelling, University of Sheffield, from 2016 to 2018, and was a panel member for the Research for Patient Benefit (RfPB) South West. In 2017-8, he was also an advisor to NICE on implementation of the NICE Fast Track Appraisal (FTA) process, and an advisor to NICE on implementation of the "Adjusted TA" process.
Prior to joining the Centre, Martin was Director of PenTAG (Peninsula Technology Assessment Group) in the Medical School at the University of Exeter, where he performed health technology assessments for the National Institute for Health and Care Excellence (NICE), and the National Institute for Health Research (NIHR) in the United Kingdom. His undergraduate training was in Mathematics at the University of Cambridge. This accounts for his interest in the mathematics and statistics of HTA.
1 Sep 2000 → 1 Dec 2003
Award Date: 1 Apr 2004
31 Oct 1999 → 31 Aug 2001
Award Date: 1 Aug 2000
Mathematical Statistics, Diploma
30 Sep 1992 → 31 Jul 1993
Award Date: 1 Jul 1993
1 Oct 1989 → 31 Jul 1992
Award Date: 1 Jul 1992
23/03/20 → 30/04/23
Services for external evaluation of Pharmaceutical Benefits Advisory Committee (PBAC) and health technology related submissions
1/11/16 → …
Technology Assessment Reports (TAR) Health technology assessments for NICE, NIHR and National Screening Committee
Hoyle, M., Mujica-Mota, R., Griffin, E., Elham, N., Packman , D., Dodman, S., Peters, J., Yang , H., Coelho , H., Long , L., Barnish , M. & Hyde, C.
1/01/16 → 1/01/21
Hyde, C., Hoyle, M., Anderson , R. & Crathorne, L.
1/01/15 → 1/01/17
Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluationTikhonova, I. A., Yang, H., Bello, S., Salmon, A., Robinson, S., Hemami, M. R., Dodman, S., Kharechko, A., Haigh, R. C., Jani, M., McDonald, T. J. & Hoyle, M., Feb 2021, In: Health Technology Assessment. 25, 8, p. 1-247 247 p.
Research output: Contribution to journal › Article › peer-reviewOpen Access
Cutler, H., Aghdaee, M., Schroeder, L., Parkinson, B., Hoyle, M. & Bilgrami, A., 14 May 2021, North Ryde, NSW: Macquarie University. 41 p.
Research output: Book/Report › Other reportOpen Access
Norman, A. & Hoyle, M., Jun 2020, Australian Government Department of Health. 41 p.
Research output: Book/Report › Commissioned reportOpen Access
Seil, E., Norman, A., McLeod, R. & Hoyle, M., 2020, Australian Government Department of Health. 276 p.
Research output: Book/Report › Commissioned report
Hoyle, Martin (Recipient), 1 Jan 2011
2019 Macquarie Business School Impact Competition, Improving health and spending money wisely: evaluating medicines and vaccines for the Australian Government
Submission into Senate Inquiry into Approval Processes for New Drug and Novel Medical Technologies in Australia. I took questions from Members of Parliament for 1/2 hour. Appearance at Members of the Standing Committee on Health.
1 Media contribution
Press/Media: Public Engagement Activities
1 Media contribution
Press/Media: Expert Comment
Improving health and spending money wisely: evaluating medicines and vaccines for the Australian Government
Henry Cutler (Participant), Bonny Parkinson (Participant), Martin Hoyle (Participant), Mutsa Gumbie (Participant), Rachel Song (Participant), Andrew Partington (Participant), Varinder Jeet (Participant), Elizabeth Seil (Participant), Alicia Norman (Participant), Virginia Mumford (Participant), Sanjyot Vagholkar (Participant), Lisa Pont (Participant) & Janaki Amin (Participant)
Impact: Quality of life impacts, Economy impacts, Policy impacts